FOLLOWUS
Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
*derricka@sina.com
收稿日期:2023-06-05,
录用日期:2023-10-08,
网络出版日期:2023-11-02,
纸质出版日期:2023-12-30
Scan QR Code
张扬, 卞爱玲, 戴荣平. 玻璃体腔内注射抗血管内皮生长因子治疗非典型类癌的虹膜睫状体转移瘤[J]. 中国医学科学杂志(英文), 2023,38(4):305-308.
Yang Zhang, Ai-Ling Bian, Rong-Ping Dai. Iridociliary Body Metastasis of Atypical Carcinoid: Case Management with Intravitreal Anti-Vascular Endothelial Growth Factor Injections[J]. Chinese medical sciences journal, 2023, 38(4): 305-308.
张扬, 卞爱玲, 戴荣平. 玻璃体腔内注射抗血管内皮生长因子治疗非典型类癌的虹膜睫状体转移瘤[J]. 中国医学科学杂志(英文), 2023,38(4):305-308. DOI: 10.24920/004268.
Yang Zhang, Ai-Ling Bian, Rong-Ping Dai. Iridociliary Body Metastasis of Atypical Carcinoid: Case Management with Intravitreal Anti-Vascular Endothelial Growth Factor Injections[J]. Chinese medical sciences journal, 2023, 38(4): 305-308. DOI: 10.24920/004268.
52岁女性被诊断为非典型支气管类癌,伴纵隔、纵隔淋巴结、乳腺和胰腺转移。虹膜和睫状体的转移瘤导致患者左眼视力逐渐下降。经玻璃体腔内注射抗血管内皮生长因子治疗,取得了理想的治疗效果。
We report a rare case involving a 52-year-old female diagnosed with an atypical bronchial carcinoid tumor with metastases to the mediastinum
hilar lymph nodes
breast
and pancreas. In additional
the patient had metastases to the iris and ciliary body
resulting in progressive vision loss in her left eye. Treatment was successful by intravitreal injections of anti-vascular endothelial growth factor.
Pelosi G , Sonzogni A , Harari S , et al . Classification of pulmonary neuroendocrine tumors: new insights . Transl Lung Cancer Res 2017 ; 6 ( 5 ): 513 - 29 . doi: 10.21037/tlcr.2017.09.04 https://dx.doi.org/10.21037/tlcr.2017.09.04 . http://tlcr.amegroups.com/ http://tlcr.amegroups.com/
Shah SU , Mashayekhi A , Shields CL , et al . Uveal metastasis from lung cancer: clinical features, treatment, and outcome in 194 patients . Ophthalmology 2014 ; 121 ( 1 ): 352 - 7 . doi: 10.1016/j.ophtha.2013.07.014 https://dx.doi.org/10.1016/j.ophtha.2013.07.014 .
Shields CL , Kaliki S , Crabtree GS , et al . Iris metastasis from systemic cancer in 104 patients: the 2014 Jerry A . Cornea 2015 ; 34 ( 1 ): 42 - 8 . doi: 10.1097/ICO.0000000000000285 https://dx.doi.org/10.1097/ICO.0000000000000285 .
Nagendran ST , Finger PT . Anti-VEGF intravitreal bevacizumab for radiation-associated neovascular glaucoma . Ophthalmic Surg Lasers Imaging Retina 2015 ; 46 ( 2 ): 201 - 7 . doi: 10.3928/23258160-20150213-08 https://dx.doi.org/10.3928/23258160-20150213-08 . https://journals.healio.com/doi/10.3928/23258160-20150213-08 https://journals.healio.com/doi/10.3928/23258160-20150213-08
Raval V , Saldanha M , Mittal R , et al . Intravitreal bevacizumab in treatment of iris metastasis from primary lung carcinoma . BMJ Case Rep 2019 ; 12 ( 9 ): e231097 . doi: 10.1136/bcr-2019-231097 https://dx.doi.org/10.1136/bcr-2019-231097 . https://casereports.bmj.com/lookup/doi/10.1136/bcr-2019-231097 https://casereports.bmj.com/lookup/doi/10.1136/bcr-2019-231097
Hidaka T , Chuman H , Nao IN . A case report of intravitreal bevacizumab for iris metastasis of small cell lung carcinoma with neovascular glaucoma . Case Rep Ophthalmol 2018 ; 9 ( 2 ): 401 - 4 . doi: 10.1159/000492713 https://dx.doi.org/10.1159/000492713 . https://www.karger.com/Article/FullText/492713 https://www.karger.com/Article/FullText/492713
Nakashima C , Keino H , Watanabe T , et al . Intravitreal bevacizumab for iris metastasis of small-cell lung carcinoma with neovascular glaucoma . Jpn J Ophthalmol 2011 ; 55 ( 1 ): 80 - 1 . doi: 10.1007/s10384-010-0892-z https://dx.doi.org/10.1007/s10384-010-0892-z .
Wolf A , von Jagow B , Ulbig M , et al . Intracameral injection of bevacizumab for the treatment of neovascular glaucoma . Ophthalmologica 2011 ; 226 ( 2 ): 51 - 6 . doi: 10.1159/000327364 https://dx.doi.org/10.1159/000327364 .
Maudgil A , Sears KS , Rundle PA , et al . Failure of intravitreal bevacizumab in the treatment of choroidal metastasis . Eye (Lond) 2015 ; 29 ( 5 ): 707 - 11 . doi: 10.1038/eye.2015.21 https://dx.doi.org/10.1038/eye.2015.21 .
关联资源
相关文章
相关作者
相关机构